Institutional investors hold a majority ownership of CELG through the 83.65% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2015, these large investors purchased a net $2.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
J.O. HAMBRO CAPITAL MANAGEMENT L... Bought 1.0 Million shares of Celgene
STANDARD LIFE INVESTMENTS LTD. Bought 648.6 Thousand shares of Celgene
USS INVESTMENT MANAGEMENT LTD. Bought 300.0 Thousand shares of Celgene